2-Bromo-N-[2-[7-Chloro-5-(2-Fluorophenyl)-2-Oxo-3H-1,4-Benzodiazepin-1-Yl]Ethyl]Acetamide

CAS: 75887-99-9

Ref. 3D-FB101616

Produktinformation

• Name: 2-Bromo-N-[2-[7-Chloro-5-(2-Fluorophenyl)-2-Oxo-3H-1,4-Benzodiazepin-1-Yl]Ethyl]Acetamide
• Marke: Biosynth
• Beschreibung: 2-Bromo-N-[2-[7-Chloro-5-(2-fluorophenyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]ethyl]acetamide is a benzodiazepine derivative that binds to the benzodiazepine receptor and is also a calcium antagonist. It has been used in clinical studies as a chronic treatment for cancer and as an anticonvulsant. 2BBA acts on benzodiazepine receptors to inhibit the release of gamma aminobutyric acid (GABA) by binding to GABA A receptors. This prevents the binding of GABA with these receptors and leads to sedation and muscle relaxation. Flunitrazepam, which is chemically similar to 2BBA, is also used as a sedative and hypnotic drug. 2BBA has affinity constants that are between 50 nM and 100 μM for benzodiazepine binding sites, while its

Chemische Eigenschaften

• Molekulargewicht: 452.7 g/mol
• Formel: C₁₉H₁₆BrClFN₃O₂
• Reinheit: Min. 95%
• InChl: InChI=1S/C19H16BrClFN3O2/c20-10-17(26)23-7-8-25-16-6-5-12(21)9-14(16)19(24-11-18(25)27)13-3-1-2-4-15(13)22/h1-6,9H,7-8,10-11H2,(H,23,26)
• InChI Key: InChIKey=RUMBKDGXDMTRBI-UHFFFAOYSA-N
• SMILES: O=C(CBr)NCCN1C(=O)CN=C(c2ccccc2F)c2cc(Cl)ccc21